Literature DB >> 24903381

MiR-145 regulates cancer stem-like properties and epithelial-to-mesenchymal transition in lung adenocarcinoma-initiating cells.

Jingwen Hu1, Mantang Qiu, Feng Jiang, Shuai Zhang, Xin Yang, Jie Wang, Lin Xu, Rong Yin.   

Abstract

MicroRNA-145 (MiR-145) is an important regulator of tumorigenesis. Our previous work indicated that miR-145 reduced the proliferation and invasion as well as the tumorosphere growth capacity in lung adenocarcinoma cells. However, the underlying molecular mechanisms remain elusive. Here, we reported that the expression level of miR-145 was downregulated in lung adenocarcinoma tissues and negatively correlated with the expression level of Oct4. MiR-145 inhibited the proliferation of lung cancer-initiating cells (LCICs), partially by regulating Oct4 expression. Furthermore, we found that miR-145 exerted repressive effect on cancer stem cell properties and inhibited epithelial-mesenchymal transition (EMT) in vitro, also partially by regulating Oct4. Finally, we confirmed the repressive effect of miR-145 on cancer stem cell properties and EMT in vivo. Taken together, these evidences suggest that miR-145 serves as a tumor suppressor which downregulates LCICs' cancer stem cell properties and EMT process by targeting Oct4, leading to the inhibition of tumor growth and metastasis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24903381     DOI: 10.1007/s13277-014-2158-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  33 in total

Review 1.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Authors:  Jing Yang; Robert A Weinberg
Journal:  Dev Cell       Date:  2008-06       Impact factor: 12.270

2.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

3.  Anticancer drugs: Curbing self-renewal of cancer-initiating cells.

Authors:  Sarah Crunkhorn
Journal:  Nat Rev Drug Discov       Date:  2014-02       Impact factor: 84.694

4.  Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

Authors:  Shih-Hwa Chiou; Mong-Lien Wang; Yu-Ting Chou; Chi-Jen Chen; Chun-Fu Hong; Wang-Ju Hsieh; Hsin-Tzu Chang; Ying-Shan Chen; Tzu-Wei Lin; Han-Sui Hsu; Cheng-Wen Wu
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

5.  Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells.

Authors:  F Yu; H Deng; H Yao; Q Liu; F Su; E Song
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

6.  Embryonic stem cell markers expression in cancers.

Authors:  Matthieu Schoenhals; Alboukadel Kassambara; John De Vos; Dirk Hose; Jérôme Moreaux; Bernard Klein
Journal:  Biochem Biophys Res Commun       Date:  2009-03-04       Impact factor: 3.575

Review 7.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

8.  Human lung cancer cell line SPC-A1 contains cells with characteristics of cancer stem cells.

Authors:  C H Zhou; S F Yang; P Q Li
Journal:  Neoplasma       Date:  2012       Impact factor: 2.575

Review 9.  Lung cancer: future directions.

Authors:  Wah K Lam; D Neil Watkins
Journal:  Respirology       Date:  2007-07       Impact factor: 6.424

10.  Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.

Authors:  Giulia Bertolini; Luca Roz; Paola Perego; Monica Tortoreto; Enrico Fontanella; Laura Gatti; Graziella Pratesi; Alessandra Fabbri; Francesca Andriani; Stella Tinelli; Elena Roz; Roberto Caserini; Salvatore Lo Vullo; Tiziana Camerini; Luigi Mariani; Domenico Delia; Elisa Calabrò; Ugo Pastorino; Gabriella Sozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-10       Impact factor: 11.205

View more
  26 in total

1.  MicroRNA-122-3p inhibits tumor cell proliferation and induces apoptosis by targeting Forkhead box O in A549 cells.

Authors:  Wen Wang; Jinsong Yang; Fenglei Yu; Wenjie Li; Li Wang; Haoyu Zou; Xia Long
Journal:  Oncol Lett       Date:  2017-12-11       Impact factor: 2.967

2.  Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling.

Authors:  Alvaro G Alvarado; Soumya M Turaga; Pratheesh Sathyan; Erin E Mulkearns-Hubert; Balint Otvos; Daniel J Silver; James S Hale; William A Flavahan; Pascal O Zinn; Maksim Sinyuk; Meizhang Li; Maheedhara R Guda; Kiran K Velpula; Andrew J Tsung; Ichiro Nakano; Michael A Vogelbaum; Sadhan Majumder; Jeremy N Rich; Justin D Lathia
Journal:  Neuro Oncol       Date:  2015-09-15       Impact factor: 12.300

Review 3.  MicroRNAs targeting prostate cancer stem cells.

Authors:  Yu-Xiang Fang; Yun-Li Chang; Wei-Qiang Gao
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-12

4.  miR-145-5p inhibits epithelial-mesenchymal transition via the JNK signaling pathway by targeting MAP3K1 in non-small cell lung cancer cells.

Authors:  Yongmei Chang; Wensen Yan; Cong Sun; Qingfeng Liu; Jun Wang; Mingzhi Wang
Journal:  Oncol Lett       Date:  2017-09-28       Impact factor: 2.967

5.  Identification of novel candidate drivers connecting different dysfunctional levels for lung adenocarcinoma using protein-protein interactions and a shortest path approach.

Authors:  Lei Chen; Tao Huang; Yu-Hang Zhang; Yang Jiang; Mingyue Zheng; Yu-Dong Cai
Journal:  Sci Rep       Date:  2016-07-14       Impact factor: 4.379

Review 6.  Regulatory mechanisms of microRNAs in lung cancer stem cells.

Authors:  Tao Fan; Wei Wang; Boyou Zhang; Yao Xu; Lei Chen; Shize Pan; Hao Hu; Qing Geng
Journal:  Springerplus       Date:  2016-10-10

7.  Drug resistance and combating drug resistance in cancer.

Authors:  Xuan Wang; Haiyun Zhang; Xiaozhuo Chen
Journal:  Cancer Drug Resist       Date:  2019-06-19

8.  DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.

Authors:  Wenjie Xia; Qiang Chen; Jie Wang; Qixing Mao; Gaochao Dong; Run Shi; YanYan Zheng; Lin Xu; Feng Jiang
Journal:  Sci Rep       Date:  2015-11-19       Impact factor: 4.379

9.  Brief Report: Inhibition of miR-145 Enhances Reprogramming of Human Dermal Fibroblasts to Induced Pluripotent Stem Cells.

Authors:  Tomas Barta; Lucie Peskova; Joseph Collin; David Montaner; Irina Neganova; Lyle Armstrong; Majlinda Lako
Journal:  Stem Cells       Date:  2015-10-09       Impact factor: 6.277

10.  Long ncRNA MALAT1 promotes cell proliferation, migration, and invasion in prostate cancer via sponging miR-145.

Authors:  Dingrong Zhang; Cheng Fang; Haibo Li; Chunyuan Lu; Jiaohong Huang; Jiancheng Pan; Zhizhao Yang; Enli Liang; Zhifei Liu; Xiaodong Zhou; Zhongcheng Xin; Yegang Chen; Qiliang Cai
Journal:  Transl Androl Urol       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.